Zero debt and an ever increasing patent portfolio. I understand there is over 300m shares in issue. At $3 per share that's close to a $1bn value. At $5 which I understand they are now raising private equity cash at means a $1.5bn valuation.
I'm sorry to say that your clearly don't understand where value comes from in biotech. Like I said to Walhall, are you going to provide any evidence?
News 
Market Data 
Discover 
